PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Royal Brisbane and Women\'s Hospital, Herston, Queensland, Australia.\', \'University of Queensland, Brisbane, Australia.\', \'Department of Endocrinology and Diabetes, Royal Brisbane and Women\'s Hospital, Herston, Queensland, Australia.\', \'Pathology Queensland, Herston, Queensland, Australia.\', \'Queensland Medical Laboratories, Murrarie, Queensland, Australia.\', \'Sullivan Nicolaides Pathology, Indooroopilly, Queensland, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.pone.0243192
?:doi
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 33270719
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
is ?:relation_isRelatedTo_publication of
?:title
  • Development of a fasting blood glucose-based strategy to diagnose women with gestational diabetes mellitus at increased risk of adverse outcomes in a COVID-19 environment.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all